A comparison of intermittent aortic cross clamping and intermittent aortic warm blood cardioplegia for myocardial protection during coronary artery bypass surgery

ISRCTN ISRCTN43177829
DOI https://doi.org/10.1186/ISRCTN43177829
Secondary identifying numbers N0265006856
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
13/03/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr JAJ Hyde
Scientific

Cardiac Services
Queen Elizabeth Hospital
Birmingham
B15 2TH
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesIs the newer technique of intra-aortic warm blood cardioplegia superior to the established technique of intermittent aortic cross-clamping for myocardial protection during coronary surgery?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSurgery: Coronary artery bypass grafting (CABG)
Intervention40 patients undergoing elective CABG will randomly be allocated into two groups of 20 patients each, to receive either intermittent cross clamp with fibrillation (XCF) or intermittent warm blood cardioplegia (WBC). Blood will be taken from in-situ intra-arterial or intravenous cannulae, at the following 12 time points: Following induction of anaesthesia; Following institution of cardiopulmonary bypass, but prior to the application of an aortic cross clamp with resultant myocardial ischaemia; 30,60,90,120 minutes and 4,6,8,12,24,28 hours following final release of the aortic cross clamp. The blood will be centrifuged for serum, which will be stored frozen at -70C until batch analysis. The analysis will be performed blind.
Intervention typeProcedure/Surgery
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/2004
Completion date01/01/2007

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants40
Key inclusion criteriaPatients undergoing elective CABG
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/01/2004
Date of final enrolment01/01/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Cardiac Services
Birmingham
B15 2TH
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

University Hospital Birmingham NHS Trust (UK)

No information available

Research Funds

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan